Trial 42756493CAN2002 Ragnar

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

42756493CAN2002 Ragnar

Full title

A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and FGFR Gene Alterations

Responsible organization

3. Med 3. Med Ismaninger Str. 22 81675 München Germany Tum

Classification	Code	Description
-		Other tumors

Phase

Status

Recruitment active

Votes

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Zielgerichtet - Therapieart: palliativ

	Function	Prename	Surname	Organization
	Responsible contact	Sylvie	Lorenzen	3. Med 3. Med Ismaninger Str. 22 81675 München Germany